Social and Non-Profit
Local Government and Administration
Jobs and Labor
Construction and Engineering
Oil and Gas
Fishing and Aquaculture
Metals and Mining
Pharmaceuticals and Biotechnology
Professional and Business Services
Forestry and Wood Industry
Books and Literature
Radio and Television
Home and Garden
Fashion and Luxury
Textile and Apparel
Travel and Hospitality
Boating and Yachting
Skiing and Winter Sports
The security settings of your browser are blocking the execution of scripts.
If you have changed your browser's security settings, you can click here.
News > Science
Scientific and Research Institutes
1Life Healthcare Inc.
7 Hygiene Myths You Should Stop Believing
City of Long Beach, CA
Official Statement by City of Long Beach Health and Human Services Department Regarding FDA Emergency Use Authorization of Booster Doses for Pfizer
City of Corpus Christi, TX
City-County Public Health Ready to Deliver Approved Booster Shots
Cengage Learning Inc.
MindTap Helped This Professor Care for Her Mother and Students [SUCCESS STORY]
FDA Advisory Committee Votes Unanimously in Favor Of COMIRNATY® Booster for Emergency Use in People 65 and Older and Certain High-risk Populations
ASHP - American Society of Health-System Pharmacists
FDA Advisory Panel Votes in Favor of COVID-19 Boosters For Certain Populations
Margaret Wood Hassan
Shaheen, Hassan Lead Letter to President Biden to Urge Opening of U.S.-Canada Border to Vaccinated Canadians by October
Astellas Pharma US Inc.
Astellas' and Pfizer's XTANDI® (enzalutamide) Reduced Risk of Death by 34% in Men with Metastatic Hormone-Sensitive Prostate Cancer in Phase 3 ARCHES Study
Astellas’ and Pfizer’s XTANDI® (enzalutamide) Reduced Risk of Death by 34% in Men with Metastatic Hormone-Sensitive Prostate Cancer in Phase 3 ARCHES Study
Protagonist Therapeutics Inc.
Protagonist Therapeutics Reports FDA Clinical Hold on Rusfertide Clinical Development Program (Form 8-K)
Copyright ©2006-2021 Public Technologies Inc. |